Human Demodex mites (Demodex folliculorum and Demodex brevis) are unique in that they are an obligate human ectoparasite that can inhabit the pilosebaceous unit lifelong without causing obvious host immune response in most cases. The mode of symbiosis between humans and human Demodex mites is unclear, while the pathogenicity of human Demodex mites in many inflammatory skin diseases is now better understood. Primary human demodicosis is a skin disease sui generis not associated with local or systemic immunosuppression. Diagnosis is often underestimated and differentiation from folliculitis, papulopustular rosacea and perioral dermatitis is not always straightforward. Dependent on the morphology and degree of inflammation, the clinical manifestations can be classified into spinulate, papulopustular, nodulocystic, crustic and fulminant demodicosis. Therapy success can be achieved only with acaricides/arachidicides. The effective doses, optimal regimen and antimicrobial resistance remain to be determined.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00105-015-3595-zDOI Listing

Publication Analysis

Top Keywords

human demodex
12
demodex mites
12
human demodicosis
8
disease sui
8
human
5
demodex
5
[primary human
4
demodicosis disease
4
sui generis]
4
generis] human
4

Similar Publications

Background Topical steroid-dependent or damaged face (TSDF) is a common condition where the widespread availability of over-the-counter topical corticosteroid (TCS)-containing products leads to their misuse and addiction. Prolonged use of these steroids on the face can result in significant side effects. Early diagnosis and cessation of steroid use are important.

View Article and Find Full Text PDF

Papulopustular rosacea is an inflammatory subtype of rosacea that can significantly impair patients' quality of life. Available treatment options range from anti-inflammatory topical and oral medications to laser and light therapies. Photodynamic therapy with aminolevulinic acid (ALA-PDT) has emerged as a more recent treatment option for papulopustular rosacea.

View Article and Find Full Text PDF

Demodex and the eye - A review.

Indian J Ophthalmol

January 2025

Cornea, Cataract and Refractive Surgery, Darshan Eye Clinic and Surgical Centre, Chennai, Tamil Nadu, India.

Demodexblepharitis (DB) has become one of the common differential diagnoses in patients presenting with red eyes in daily clinics. In this review article, we have incorporated a detailed discussion about the mite and the various mechanisms by which it causes different signs and symptoms, the risk factors, and diagnostic methods with current and emerging treatment modalities. Because of the chronic symptoms and rather a late diagnosis, DB considerably affects patients' quality of life.

View Article and Find Full Text PDF

The Effect of Terpinen-4-ol on Human Corneal Epithelium.

Transl Vis Sci Technol

December 2024

Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Purpose: To investigate the toxicity of terpinen-4-ol (T4O) on primary cultured human corneal epithelial cells (HCECs).

Methods: HCECs were exposed to various concentrations (0%-0.1%) of T4O for 15 minutes to 72 hours.

View Article and Find Full Text PDF
Article Synopsis
  • Dermatologists struggle with treating demodicosis due to its recurrence and difficulty in normalizing densities even after improvement.
  • The study evaluated the effectiveness of oral ivermectin (200 µg/kg/week) in improving clinical symptoms and reducing density in 40 demodicosis patients, comparing those with lower and higher densities.
  • Results showed 75% of patients achieved clinical remission, with quicker remission for patients with lower densities (28 days) compared to those with higher densities (56 days).
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!